Until recently, clinicians have had limited pharmaceutical options in management this disorder
Monitoring and follow-up should be arranged at 3 months initially to assess HbA1c response, tolerability, weight change, blood pressure, and renal function
Supports Long-Term Health Beyond weight loss, GLP-1 injections help lower the risk of obesity-related conditions like diabetes, high blood pressure, and heart disease
Indeed, the presence of sarcopenia and obesity, as well as SO with its dual impact, contributes substantially to national and global healthcare expenditures and serves as a prognostic factor for the growing burden on public health [5, 6]
Skin: Structure and Functions
We have to undo problems that they have from medicines that they got in random ways. Its unlikely the drugs will stay on the FDAs shortage list forever